Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al
[PMID: 30670548] PubMed record related to this compound for laboratory literature review
I would like to thank Paris Rich Bingham and Sebastian Butts for research assistance, and Rasa Siniakovas and Chris Miller for editorial assistance
Serious Pancreatic Risk: Pancreatitis Acute pancreatitis has been reported rarely in users using tirzepatide
Physical changes make it impossible to eat large amounts
Among patients without CKD, minimal increases in serum creatinine were observed for patients on a GLP-1 compared to those who were not prescribed a GLP-1: 0.01 mg/dL for semaglutide, 0.01 mg/dL for liraglutide, and 0.02 mg/dL for tirzepatide